Scleroderma and the Esophagus

被引：9
作者：
Ahuja, Nitin K. [1 ]
Clarke, John O. [2 ]
机构：
[1] Univ Penn, Div Gastroenterol & Hepatol, 3400 Civ Ctr Blvd 7 South Pavil, Philadelphia, PA 19104 USA
[2] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, 430 Broadway St,Pavil C,3rd Floor,C-343, Redwood City, CA 94063 USA
来源：
GASTROENTEROLOGY CLINICS OF NORTH AMERICA | 2021年 / 50卷 / 04期
关键词：
Scleroderma; Dysphagia; Aperistalsis; Sjogren; Lupus; Fibromyalgia Ehler-Danlos; Myositis; PROGRESSIVE SYSTEMIC-SCLEROSIS; CONNECTIVE-TISSUE DISEASE; GASTROESOPHAGEAL-REFLUX DISEASE; EHLERS-DANLOS-SYNDROME; UPPER GASTROINTESTINAL MOTILITY; INTERSTITIAL LUNG-DISEASE; HIGH-RESOLUTION MANOMETRY; PULMONARY-FUNCTION; METOCLOPRAMIDE RESPONSE; HEPATIC MANIFESTATIONS;
D O I：
10.1016/j.gtc.2021.08.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：905 / 918
页数：14
相关论文
共 50 条
  • [31] Oesophageal involvement in scleroderma
    Sueto, G.
    Czirjak, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (03) : S2 - S4
  • [32] Current Therapeutic Approaches in Scleroderma: Clinical Models of Effective Antifibrotic Therapies
    Johnson, Sindhu R.
    Furst, Daniel E.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2020, 6 (04) : 382 - 393
  • [33] Effect of mycophenolate sodium in scleroderma-related interstitial lung disease
    Pilar Simeon-Aznar, Carmen
    Fonollosa-Pla, Vicent
    Tolosa-Vilella, Carles
    Selva-O'Callaghan, Albert
    Solans-Laque, Roser
    Vilardell-Tarres, Miquel
    CLINICAL RHEUMATOLOGY, 2011, 30 (11) : 1393 - 1398
  • [34] Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease
    Tzelepis, G. E.
    Plastiras, S. C.
    Karadimitrakis, S. P.
    Vlachoylannopoulos, P. G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (05) : 734 - 739
  • [35] Improving life expectancy of patients with scleroderma: results from the South Australian Scleroderma Register
    Kennedy, Nicholas
    Walker, Jenny
    Hakendorf, Paul
    Roberts-Thomson, Peter
    INTERNAL MEDICINE JOURNAL, 2018, 48 (08) : 951 - 956
  • [36] Scleroderma Lung DiseaseAppropriate Management
    David Alexander Brown
    Samuel N. Breit
    BioDrugs, 1997, 8 : 185 - 192
  • [37] Primary scleroderma myocardial disease
    Kahan, Andre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2011, 195 (01): : 69 - 76
  • [38] Pseudohypertension in a patient with diffuse scleroderma
    Rosner, MH
    Okusa, MD
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04)
  • [39] Pulmonary arterial hypertension in the setting of scleroderma is different than in the setting of lupus: A review
    Bazan, Isabel S.
    Mensah, Kofi A.
    Rudkovskaia, Anastasiia A.
    Adonteng-Boateng, Percy K.
    Herzog, Erica L.
    Buckley, Lenore
    Fares, Wassim H.
    RESPIRATORY MEDICINE, 2018, 134 : 42 - 46
  • [40] The spectrum of scleroderma lung disease
    Highland, Kristin B.
    Garin, Margaret C.
    Brown, Kevin K.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 28 (04) : 418 - 429
12345